Association between radiotherapy timing and intracranial outcomes in EGFR-mutant NSCLC with brain metastases treated with EGFR-TKIs - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Impact of Radiotherapy Timing on Intracranial Outcomes in Patients with EGFR-Mutated NSCLC and Brain Metastases Undergoing Treatment with EGFR-TKIs

  • By

  • Qi Liu

  • Jian Shi

  • Ruiyu Liu

  • Zhuofan Wang

  • Rong Qiu

  • Yunfan Wu

  • Juan Li

  • Yuxiang Wang

  • June 22, 2026

Share

Original Source(s)

Association between radiotherapy timing and intracranial outcomes in EGFR-mutant NSCLC with brain metastases treated with EGFR-TKIs

  • by Qi Liu, Jian Shi, Ruiyu Liu, Zhuofan Wang, Rong Qiu, Yunfan Wu, Juan Li, Yuxiang Wang

  • June 22, 2026

Related Content

Toward Precision Cardio-Oncology in Breast Radiotherapy

Correction: Beyond inhibition: harnessing the DRD2–VEGF-A feedback loop for precision anti-angiogenesis therapy in cancer

Fellowship-Trained Neuro-Oncologist Nishika Karbhari, M.D., Joins Baptist Health Herbert Wertheim Cancer Institute

Fellowship-trained neuro-oncologist Nishika Karbhari, M.D., has joined Baptist Health Herbert Wertheim Cancer Institute.

  • by

  • September 3, 2026

  • 2 min